Publication | Closed Access

Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5′-DFUR in breast cancer MCF7 cells

Breast OncologyTranscriptomic ResponseMedicineCancer Cell BiologyCancer GenomicsBreast CancerMolecular OncologyNucleoside-derived Drug 5′-DfurRadiation OncologyCancer BiologyCell BiologyTumor Biology